Clinical Trial
Accepted on 22 Jul 2025
Medication Beliefs and Adherence During and After Pregnancy among Women at Risk for Gestational Hypertensive Disorders
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1610273
83 Publications
Volume 5 - 2025
Editorial
Accepted on 18 Jul 2025
EDITORIAL: Safety of Corticosteroids in Respiratory Medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1656299
- 178 views
Perspective
Accepted on 15 Jul 2025
Frontiers in Drug Safety and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1644680
- 156 views
Review
Published on 20 Jun 2025
Centralized daily drug management in clinical trial institutions and specific implementation plans
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1620314
- 557 views
Original Research
Accepted on 02 Jun 2025
Identifying regulatory outcomes of non-interventional Post Authorisation Safety Studies in the European repository of studies using publicly available information
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1574430
- 431 views
Methods
Published on 26 May 2025
Federated learning: a privacy-preserving approach to data-centric regulatory cooperation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579922
- 1,422 views
Review
Published on 24 Apr 2025
Corticosteroids in lung cancer
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1528468
- 1,556 views
Original Research
Published on 13 Mar 2025
Developing decision support algorithm for hypertension medications for use in a digital therapeutic system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
- 870 views
Editorial
Published on 11 Mar 2025
Editorial: External control arms for single-arm studies: methodological considerations and applications
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579171
- 1,160 views
Perspective
Published on 13 Feb 2025
Implementing tokenization in clinical research to expand real-world insights
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1519307
- 2,145 views
Volume 4 - 2024
Review
Published on 17 Jan 2025
Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1519142
- 1,598 views
Original Research
Published on 16 Jan 2025
The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1402684
- 1,709 views
Original Research
Published on 06 Jan 2025
Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1480515
- 3,036 views
Review
Published on 18 Dec 2024
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1418050
- 1,860 views
Original Research
Published on 06 Dec 2024
Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1497116
- 1,087 views
Mini Review
Published on 13 Nov 2024
Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1428831
- 1,613 views